What is the share price of Zora Pharma Ltd (524438)?

Company share prices are keep on changing according to the market conditions. The current trading price of Zora Pharma Ltd (524438) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Zora Pharma?

The latest standalone P/E ratio of Zora Pharma as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Zora Pharma Ltd (524438)?

The latest standalone P/B ratio of Zora Pharma Ltd (524438) as of 01-Jan-1970 is -0.57.

What is the 52-week high and low of Zora Pharma Ltd (524438)?

The 52-week high of Zora Pharma Ltd (524438) is Rs. 0.00 and the 52-week low is Rs. 0.00.

Zora Pharma Ltd (524438) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Zora Pharma Ltd (524438)
Brand: Zora Pharma

Zora Pharma Ltd (524438)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524438 NSE: Pharmaceuticals & Drugs | Small Cap | Zora Pharma Share Price

Zora Pharma Ltd (524438)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524438 NSE: Pharmaceuticals & Drugs | Small Cap | Zora Pharma Share Price

Key Metrics

Valuation Multiples

Market Cap

₹1 Cr.

Current Price

₹0

52-Week Low / High

₹0 / 0

TTM EPS

₹-1.2

TTM Sales

₹0 Cr.

Book Value per Share

₹-4.2

P/E Ratio

0.00

Industry PE

46.6

Price to Book (P/B)

-0.57

Price to Sales (P/S)

37.59

EV/EBITDA

-92.37

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

0.00%

Return on Capital Employed (ROCE)

-15.49%

Return on Assets (ROA)

-28.10%

Operating Profit Margin

-69,179.8%

Net Profit Margin

-743551.05%

Gross Profit Margin

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Steady versus 3-year growth rate

-100%

Operating Profit Growth (1 Year)

Net Profit Growth (1 Year)

Asset Quality

Promoter Holding

Pledged shares (%) of Promoter's holding (%)

Reserves

₹-9 Cr.

Equity

₹6.2 Cr.

Face Value

₹10

All Time Low / High

₹1.20 / 12.85

Zora Pharma stock performance

Key Ratios

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'98	Mar'99	Sep'00	Sep'01	Sep'02	Sep'03	Sep'04	Sep'05	TTM
ROCE % ⓘ	14.3%	12.9%	-39.7%	-39.5%	-7.1%	-10.9%	-13.8%	-15.5%	-
Growth Parameters ⓘ
Sales ⓘ	16.2	15.6	7.2	1.7	0.5	0.3	0	0	0
Sales YoY Gr.	-	-3.5%	-53.8%	-75.9%	-73%	-40.4%	-89.3%	-100%	-
Adj EPS ⓘ	1	0.5	-10.7	-10.1	-4.1	-4.5	-4.6	-4.5	-1.2
YoY Gr.	-	-53.6%	-2484.4%	NA	NA	NA	NA	NA	-
BVPS (₹) ⓘ	14.2	14.5	-1.4	-12.2	-16.2	-20.5	-25	-29.6	-4.2
Adj Net Profit ⓘ	0.6	0.3	-6.7	-6.3	-2.6	-2.8	-2.9	-2.8	-1
Cash Flow from Ops. ⓘ	1.9	0.7	-1.8	-2.3	-3	-2.9	-0.3	-0.3	-
Debt/CF from Ops. ⓘ	5.1	14.8	-5.3	-6.8	-5.8	-6.7	-62.8	-75.6	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	-100%	-100%	-100%
Adj EPS ⓘ	NA	NA	NA	NA
BVPSⓘ	NA	NA	NA	NA
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Mar'98	Mar'99	Sep'00	Sep'01	Sep'02	Sep'03	Sep'04	Sep'05	TTM
Return on Equity % ⓘ	6.6	3.1	-244.5	148.9	29.5	24.4	20.1	16.6	7.2
Op. Profit Mgn % ⓘ	21.2	22.7	-41.4	-171.8	-181.6	-151.9	-1228.5	-69179.8	-359.5
Net Profit Mgn % ⓘ	3.7	1.8	-92.7	-361.8	-543.9	-973.8	-9483.6	-743551.1	-1887.6
Debt to Equity ⓘ	1.1	1.2	-10.4	-2.1	-1.7	-1.5	-1.4	-1.3	-
Working Cap Days ⓘ	0	229	250	735	1,868	2,667	20,733	14,97,531	0
Cash Conv. Cycle ⓘ	0	115	133	202	202	454	10,638	8,00,596	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'98	Mar'99	Sep'00	Sep'01	Sep'02	Sep'03	Sep'04	Sep'05
Sales	16.21	15.64	10.84	1.74	0.47	0.28	0.03	0
Operating Expenses ⓘ +	12.78	12.13	15.57	4.89	1.33	0.73	0.40	0.26
Manufacturing Costs	2.70	2.26	2.20	0.42	0.41	0.12	0.07	0.07
Material Costs	8.45	8.09	10.96	3.83	0.49	0.27	0.09	0
Employee Cost	0.71	0.76	0.98	0.16	0.18	0.08	0.09	0.10
Other Costs ⓘ	0.92	1.03	1.42	0.48	0.25	0.26	0.15	0.10
Operating Profit ⓘ	3.44	3.51	-4.73	-3.15	-0.86	-0.44	-0.37	-0.26
Operating Profit Margin (%)	21.2%	22.4%	-43.7%	-181.0%	-181.0%	-155.0%	-1,228.5%	-69,179.8%
Other Income ⓘ +	0.44	0.41	0.43	0.24	1.33	0.59	0.32	0.16
Exceptional Items ⓘ	0	0	0	0	0	0	0	0
Interest ⓘ	1.88	2.13	3.85	2.30	2.02	2	1.96	1.95
Depreciation ⓘ	1.25	1.48	2.05	1.18	1.03	0.93	0.84	0.77
Profit Before Tax ⓘ	0.75	0.31	-10.20	-6.39	-2.57	-2.78	-2.85	-2.82
Tax ⓘ	0.05	0.03	0	0	0	0	0	0
Profit After Tax	0.70	0.27	-10.20	-6.39	-2.57	-2.78	-2.85	-2.83
PAT Margin (%)	4.3%	1.8%	-94.2%	-367.0%	-543.0%	-976.0%	-9,468.9%	-7,43,551.1%
Adjusted EPS (₹)	1.1	0.4	-16.4	-10.2	-4.1	-4.5	-4.6	-4.5
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Zora Pharma - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'98	Mar'99	Sep'00	Sep'01	Sep'02	Sep'03	Sep'04	Sep'05
Equity and Liabilities
Shareholders Fund +	9.08	9.25	-1.03	-7.42	-9.98	-12.77	-15.61	-18.44
Share Capital ⓘ	6.24	6.24	6.24	6.24	6.24	6.24	6.24	6.24
Reserves ⓘ	2.83	3	-7.28	-13.66	-16.23	-19.01	-21.86	-24.68
Debt +	9.52	10.40	13.87	15.79	17.48	19.65	21.61	23.70
Long Term Debt	9.52	10.40	13.87	15.79	17.48	19.65	21.61	23.70
Short Term Debt	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0
Trade Payables	2.90	2.89	5.14	5.67	5.23	4.17	3.90	3.81
Others Liabilities ⓘ	2.54	2.92	0.58	0.58	0.57	0.57	0.57	0.57
Total Liabilities ⓘ	24.04	25.46	18.56	14.62	13.30	11.63	10.47	9.65
Fixed Assets
Net Fixed Assets ⓘ +	13.39	14.22	11.69	10.18	9.20	8.25	7.41	6.64
Gross Block	17.50	19.73	18.96	17.83	17.88	17.83	17.73	17.73
Accumulated Depreciation	4.11	5.50	7.27	7.65	8.68	9.58	10.32	11.09
CWIP ⓘ	0.37	0	1.14	1.14	1.14	1.14	1.14	1.14
Investments ⓘ	0.04	0.04	0	0	0	0	0	0
Inventories	6.43	6.71	3.37	1	0.54	0.35	0.28	0.28
Trade Receivables	2.14	2.85	0.84	0.83	1.08	0.77	0.57	0.54
Cash Equivalents	0.45	0.46	0.44	0.46	0.44	0.37	0.34	0.32
Others Assets ⓘ	1.22	1.18	1.09	1.02	0.90	0.74	0.72	0.73
Total Assets ⓘ	24.04	25.46	18.56	14.62	13.30	11.63	10.47	9.65

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'98	Mar'99	Sep'00	Sep'01	Sep'02	Sep'03	Sep'04	Sep'05
Cash Flow From Operating Activity ⓘ +	1.87	0.71	-2.64	-2.32	-3.02	-2.92	-0.34	-0.31
PBT ⓘ	0.70	0.27	-10.28	-6.39	-2.57	-2.78	-2.85	-2.83
Adjustment ⓘ	2.80	3.34	5.90	3.54	1.80	2.43	2.50	2.56
Changes in Working Capital ⓘ	0.28	-0.63	5.62	2.82	-0.23	-0.56	0	-0.05
Tax Paid ⓘ	-0.02	-0.15	-0.03	0	0	0	0	0
Cash Flow From Investing Activity ⓘ +	-3.89	-1.52	-0.67	0.44	1.28	0.60	0.32	0.16
Capex	-4.33	-1.93	-0.89	0.19	-0.05	0.01	0.01	0
Net Investments	0.02	0	0.04	0.03	0	0	0	0
Others ⓘ	0.42	0.41	0.17	0.21	1.33	0.59	0.31	0.16
Cash Flow From Financing Activity ⓘ +	2.04	0.82	3.29	1.90	1.71	2.25	-0.01	0.13
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	-0.52	0	0	0	0	0	0	0
Others ⓘ	2.56	0.82	3.29	1.90	1.71	2.25	-0.01	0.13
Net Cash Flow ⓘ	0.02	0	-0.02	0.03	-0.02	-0.07	-0.03	-0.03

Financial Ratio

PARTICULARS	Mar'98	Mar'99	Sep'00	Sep'01	Sep'02	Sep'03	Sep'04	Sep'05
Ratios
ROE (%)	7.9	3.06	N/A	N/A	N/A	N/A	N/A	N/A
ROCE (%)	14.32	12.87	N/A	N/A	N/A	N/A	N/A	N/A
Asset Turnover Ratio	0.7	0.65	0.52	0.11	0.04	0.02	0	0
PAT to CFO Conversion(x)	2.67	2.63	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	46.70	56.90	59.30	160.50	707.20	1,164.20	8,161.40	0
Inventory Days	140.10	149.90	162	419.70	567	559.10	3,866.20	0
Payable Days	125.20	130.70	133.70	515.60	4,047.60	6,395.10	0	0

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Zora Pharma Ltd FAQs

The current trading price of Zora Pharma on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Zora Pharma stood at ₹1.47 Cr

The latest P/E ratio of Zora Pharma as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Zora Pharma as of 31-Dec-1969 is -0.57.

The 52-week high of Zora Pharma is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Zora Pharma is ₹0.04 ( Cr.) .

Data is not available for this company.

No data found

About Zora Pharma Ltd

Zora Pharma Ltd was incorporated as a private limited company registered with the Registrar of Companies, Gujarat vide Certificate of Incorporation dated February 21, 1985 and was subsequently converted into a Public Limited Company vide special resolution passed on 9th July, 1993. The Company was promoted by the Patankar family in 1985 and since 1986 has been engaged in the manufacture of TMP, a bulk drug. The company is situated at 604, Aniket C.G. ROAD, Navarangpura Ahmedabad, Gujarat, India.

In the beginning it started manufacturing & marketing Trimethodprim an antibacterial bulk drug, by importing the major intermediate 3,4,5 Trimethoxybenzaldehyde. In view of problems faced by Comp. is getting imported intermediate in time & increase in cost due to Exchange Rate Fluctuations etc., the Comp. couldn't perform well till 1991.

The Comp. decided to start manufacturing Trimethoprim from basic stage & successfully developed the process technology for manufacture of 3,4,5 Trimethoxybenezaldehyde from indigenously available raw material in 1991. This was the turning point in the history of Company.

Zora Pharma was amalgamated on 01/01/2010(record date) with Intas Pharmaceuticals Ltd. (an unlisted company) pursuant to the sanctioned Scheme of Rehabilitation by BIFR. Intas Pharmaceuticals Ltd. issued and alloted to the shareholders of Zora Pharma Ltd. in the ratio of 1 (ONE) 5% Redeemable preference share of the face value of Rs10- each (redeemable within 60 months from the date of the sanction of the scheme) of Intas Pharmaceuticals Ltd. for every 48(FORTY EIGHT) Equity Shares of the face value of Rs.10/- each held in Zora Pharma Ltd.

Zora Pharma Ltd (524438)

Zora Pharma Ltd (524438)

Zora Pharma stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Zora Pharma - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Zora Pharma Ltd FAQs

About Zora Pharma Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Zora Pharma Ltd (524438)

Zora Pharma Ltd (524438)

Zora Pharma stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Zora Pharma - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Zora Pharma Ltd FAQs

What is the share price of Zora Pharma?

What is the market cap of Zora Pharma?

What is the P/E ratio of Zora Pharma?

What is the P/B ratio of Zora Pharma?

What is the 52-week high and low of Zora Pharma?

What is the TTM revenue of Zora Pharma?

Is a good quality company?

Is undervalued or overvalued?

Is a good buy now?

About Zora Pharma Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.